Apheresis Companies | Market Research Future

Top Industry Leaders in the Apheresis Market

Latest Apheresis Companies Update

Nov 2023: Fresenius Medical Care's structural transformation has progressed steadily. Following the implementation of the new operating model and matching financial reporting, the conversion of legal forms to simplify the governance structure is still scheduled to be finished by December 1, 2023. Fresenius Medical Care still effectively carries out its turnaround and operational efficiency goals. The FME25 transformation initiative produced savings of EUR 97 million in the third quarter, amounting to EUR 232 million for the first nine months of the year. By the end of 2023, the Company is on course to generate sustainable savings of between 250 and 300 million euros, and by the end of 2025, it will have saved 650 million euros.

Jan 2023: By the agreement, Asahi Kasei Medical expands its bioprocess business by including a biopharmaceutical contractual development and production organization (CDMO). Bionova is a company that develops and produces treatments using recombinant proteins. The acquisition's closing is contingent upon receiving the necessary regulatory permissions. With over 100 workers, Bionova is a portfolio company of Great Point Partners, a private investment organization with its headquarters in Greenwich, Connecticut, concentrating on the healthcare sector. According to Asahi Kasei Medical, process development and GMP manufacturing operations are essential to the general business success of biopharma customers as well as the introduction of new medications. Bionova is well-known in the industry for its process development skills.

List of Apheresis Key companies in the market